In reply

JAMA Internal Medicine

Volumn 175, Issue 7, 2015, Pages 1245-1247

  Hernandez, Inmaculada ^a   Zhang, Yuting ^a  

^a UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DABIGATRAN; WARFARIN; ANTICOAGULANT AGENT; ANTITHROMBIN; BENZIMIDAZOLE DERIVATIVE; BETA ALANINE;

ANTICOAGULANT THERAPY; ATRIAL FIBRILLATION; BLEEDING; BRAIN HEMORRHAGE; CHRONIC KIDNEY DISEASE; COMORBIDITY; GASTROINTESTINAL HEMORRHAGE; HOSPITAL PATIENT; HUMAN; LETTER; MEDICARE; OUTPATIENT; PRESCRIPTION; PRIORITY JOURNAL; PROPENSITY SCORE; RISK FACTOR; ANALOGS AND DERIVATIVES; CHEMICALLY INDUCED; FEMALE; MALE;

ANTICOAGULANTS; ANTITHROMBINS; ATRIAL FIBRILLATION; BENZIMIDAZOLES; BETA-ALANINE; FEMALE; HEMORRHAGE; HUMANS; MALE; WARFARIN;

EID: 84937439468     PISSN: 21686106     EISSN: None     Source Type: Journal    
DOI: 10.1001/jamainternmed.2015.1299     Document Type: Letter

References (8)

1. Hernandez I, Baik SH, Pi?era A, Zhang Y. Risk of bleeding with dabigatran in atrial fibrillation. JAMA Intern Med. 2015;175(1):18-24.
2. Graham DJ, Reichman ME,WerneckeM, et al. Cardiovascular, bleeding, and mortality risks in elderly Medicare patients treated with dabigatran or warfarin for nonvalvular atrial fibrillation. Circulation. 2015;131(2):157-164.
3. Miyares MA. One-year risk of bleeding with dabigatran in patients with atrial fibrillation. JAMA Intern Med. 2015;175(7). doi:10.1001/jamainternmed.2015.1271.
4. Liu S, Kim CO, Lucyk SN. Dosage of dabigatran as a risk factor for bleeding in atrial fibrillation. JAMA Intern Med. 2015;175(7). doi:10.1001/jamainternmed.2015.1286.
5. Henriksen DP, Hansen MR, Damkier P. Patient characteristics and risk of bleeding with dabigatran in atrial fibrillation. JAMA Intern Med. 2015;175(7). doi:10.1001/jamainternmed.2015.1289.
6. Zint K, Kreuzer J. Amethodological appraisal of recent real-world data publications on dabigatran. JAMA Intern Med. 2015;175(7). doi:10.1001/jamainternmed.2015.1280.
7. Chronic Conditions DataWarehouse. 27 Chronic condition algorithms. 2014; https://www.ccwdata.org/cs/groups/public/documents/document/ccw-condition-categories.pdf. Accessed February 22, 2015.
8. Klil-Drori A, Azoulay L. The role of selection in the risk of bleeding with dabigatran in patients with atrial fibrillation. JAMA Intern Med. 2015;175(7). doi:10.1001/jamainternmed.2015.1277.